Squarepoint Ops LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 193,794 shares of ARWR stock, worth $3.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

193,794

Previous 383,826 49.51%

Holding current value

$3.8 Million

Previous $9.98 Million 62.4%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.36 - $29.54 $3.68 Million - $5.61 Million	-190,032 Reduced 49.51%	193,794 $3.75 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $8.39 Million - $10.8 Million	383,826 New	383,826 $9.98 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $3.6 Million - $5.92 Million	-142,952 Reduced 74.19%	49,734 $1.77 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $4.42 Million - $7.18 Million	186,477 Added 3003.33%	192,686 $4.89 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $28,392 - $41,127	-1,014 Reduced 14.04%	6,209 $251,000
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $3.82 Million - $6.24 Million	-129,072 Reduced 94.7%	7,223 $239,000
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $3.24 Million - $5.9 Million	116,502 Added 588.6%	136,295 $4.8 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $784,198 - $1.38 Million	19,793 New	19,793 $910,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $404,364 - $574,352	-6,961 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $42,734 - $62,190	732 Added 11.75%	6,961 $435,000
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $387,132 - $562,603	6,229 New	6,229 $516,000
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $926,091 - $1.8 Million	-21,134 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $130,780 - $201,901	-3,938 Reduced 15.71%	21,134 $910,000
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $1.12 Million - $1.86 Million	-42,948 Reduced 63.14%	25,072 $1.08 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $1.26 Million - $3.86 Million	61,209 Added 898.68%	68,020 $1.96 Million
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $184,992 - $479,967	-6,574 Reduced 49.11%	6,811 $432,000
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $239,622 - $318,097	-9,125 Reduced 40.54%	13,385 $377,000
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $1.19 Million - $1.96 Million	-68,144 Reduced 75.17%	22,510 $597,000
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $900,195 - $1.51 Million	74,705 Added 468.4%	90,654 $1.66 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $171,292 - $314,195	15,949 New	15,949 $198,000
Q1 2018 May 15, 2018	SELL	$3.72 - $7.64 $190,464 - $391,168	-51,200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $109,272 - $156,600	34,800 Added 212.2%	51,200 $188,000
Q3 2017 Nov 14, 2017	BUY	$1.69 - $4.33 $27,716 - $71,012	16,400	16,400 $71,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Arrowhead Pharmaceuticals, Inc. Transaction History